Investigational Medical Laser Significant Risk Device (Laser Notice 31)

Issue Date: May 18, 1981
Issued by: Center for Devices and Radiological Health
Topic(s): Laser Notice
Status: Final

Investigational Medical Laser Significant Risk Device (Laser Notice 31)

This guide provides: Criteria for Considering an Investigational Medical Laser Device as a Significant Risk Device

Download the Guidance Document

webmaster1981-05-18T00:00:00+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.